Evidence map›Paper›PMID 26415143›Full record

ReviewAntioxidants & redox signaling2015

Clinical Relevance of Biomarkers of Oxidative Stress.

Jeroen Frijhoff, Paul G Winyard, Neven Zarkovic, Sean S Davies, Roland Stocker, David Cheng, Annie R Knight, Emma Louise Taylor, Jeannette Oettrich, Tatjana Ruskovska and 7 more

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 449 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
449citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

449 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

389 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jeroen Frijhoff1 Faculty of Health, Medicine and Life Sciences, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University , Maastricht, the Netherlands .
Paul G Winyard2 University of Exeter Medical School , Exeter, United Kingdom .
Neven Zarkovic3 LabOS, Rudjer Boskovic Institute , Zagreb, Croatia .
Sean S Davies4 Department of Medicine, Vanderbilt University , Nashville, Tennessee.
Roland Stocker6 Vascular Biology Division, Victor Chang Cardiac Research Institute , Darlinghurst, New South Wales, Australia .
David Cheng6 Vascular Biology Division, Victor Chang Cardiac Research Institute , Darlinghurst, New South Wales, Australia .
Annie R Knight2 University of Exeter Medical School , Exeter, United Kingdom .
Emma Louise Taylor2 University of Exeter Medical School , Exeter, United Kingdom .
Jeannette Oettrich1 Faculty of Health, Medicine and Life Sciences, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University , Maastricht, the Netherlands .
Tatjana Ruskovska8 Faculty of Medical Sciences, Goce Delcev University , Stip, Macedonia .
Ana Cipak Gasparovic3 LabOS, Rudjer Boskovic Institute , Zagreb, Croatia .
Antonio Cuadrado9 Centro de Investigación Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) , ISCIII, Madrid, Spain .
Daniela Weber13 Department of Molecular Toxicology, German Institute of Human Nutrition (DIfE) , Nuthetal, Germany .
Henrik Enghusen Poulsen14 Faculty of Health Science, University of Copenhagen , Copenhagen, Denmark .
Tilman Grune13 Department of Molecular Toxicology, German Institute of Human Nutrition (DIfE) , Nuthetal, Germany .
Harald H H W Schmidt1 Faculty of Health, Medicine and Life Sciences, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University , Maastricht, the Netherlands .
Pietro Ghezzi16 Brighton and Sussex Medical School , Brighton, United Kingdom .

Funding

Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
NHLBI NIH HHS HL116263NHLBI NIH HHS P01 HL116263
6 · The paper itself

Abstract

significanceOxidative stress is considered to be an important component of various diseases. A vast number of methods have been developed and used in virtually all diseases to measure the extent and nature of oxidative stress, ranging from oxidation of DNA to proteins, lipids, and free amino acids. RECENT ADVANCES: An increased understanding of the biology behind diseases and redox biology has led to more specific and sensitive tools to measure oxidative stress markers, which are very diverse and sometimes very low in abundance. CRITICAL ISSUES: The literature is very heterogeneous. It is often difficult to draw general conclusions on the significance of oxidative stress biomarkers, as only in a limited proportion of diseases have a range of different biomarkers been used, and different biomarkers have been used to study different diseases. In addition, biomarkers are often measured using nonspecific methods, while specific methodologies are often too sophisticated or laborious for routine clinical use. FUTURE DIRECTIONS: Several markers of oxidative stress still represent a viable biomarker opportunity for clinical use. However, positive findings with currently used biomarkers still need to be validated in larger sample sizes and compared with current clinical standards to establish them as clinical diagnostics. It is important to realize that oxidative stress is a nuanced phenomenon that is difficult to characterize, and one biomarker is not necessarily better than others. The vast diversity in oxidative stress between diseases and conditions has to be taken into account when selecting the most appropriate biomarker.

Indexed as

Oxidative StressAnimalsBiomarkersDNA DamageGlycation End Products, AdvancedHumansLipid PeroxidationLipoproteins, LDLMalondialdehydeProtein CarbonylationReactive Oxygen SpeciesBiomarkersGlycation End Products, AdvancedLipoproteins, LDLMalondialdehydeoxidized low density lipoproteinReactive Oxygen Species

Identifiers

PMID26415143
PMCPMC4657513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.